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Edited by Ned ManteiAbstract Synapses mediate communication between neurons,
thus playing a fundamental role in information processing in
the CNS. Neuroligins form a family of heterophilic synaptic cell
adhesion molecules, and neuroligin 1 (NL1) has been shown to be
involved in the formation of excitatory synapses and have been
suggested to associate indirectly with NMDA receptors by com-
mon binding to PSD95. A mutation in neuroligin 3 (Arg451Cys-
NL3, human sequence numbering) identiﬁed in autistic patients
is associated with altered spine density and has reduced binding
capacity for its presynaptic partner b-neurexin. Here, we inves-
tigated the role of NL1 and the homologous NL1 mutation
Arg473Cys-NL1 (R473C-NL1) in excitatory synaptic transmis-
sion and NMDA receptor distribution. We demonstrate that
R473C-NL1, when expressed in cultured hippocampal neurons,
can induce a dramatic increase in NMDA current amplitude
and that this change is accompanied by NMDA receptor cluster-
ing in the postsynaptic cell.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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clustering; Synaptic transmission1. Introduction
Neuroligins 1-3 are brain-speciﬁc heterophilic synaptic cell
adhesion molecules localized to postsynaptic sites [1–4]. They
bind across the synapse to beta-neurexin, a member of a family
of neuronal cell surface proteins formed by three alternately
spliced genes [5]. Expression of NL1 in non-neuronal cells
triggers presynaptic diﬀerentiation in an ex vivo model system
[6–8], and has been shown to form functional excitatory, gluta-
matergic synapses between cerebellar granule cells and
HEK293 cells [9]. Disruption of neuronal development and/
or postnatal synaptic plasticity due to neurexin or neuroligin
mutations might result in syndromes such as autism spectrum
disorder (ASD) and mental retardation [10–13]. A recent study
has described a mutation of the X-linked gene encoding neu-
roligin-3 (NL3) in one set of siblings with ASD. This single
amino acid polymorphism encodes for Cys instead of Arg451
[11], a largely conserved residue in the a/b-hydrolase fold fam-
ily. The extracellular domains of rat NL1 and 3 share 74.1%
amino acid identity. Initial investigations of the biochemical
consequences of the Arg473Cys-NL3 mutation (the rat homo-*Corresponding author. Fax: +1 403 283 7137.
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vealed that while normal cellular processing targets neuoligin
to the cell membrane, the Cys mutation results in intracellular
retention of neuroligin when expressed in HEK293 cells [14].
However, this mutant is transported to the membrane under
high expression levels in rat hippocampal neurons [15].
NL1 binds to a PDZ domain of the postsynaptic protein
PSD95 [16], as do the N-methyl D-aspartate (NMDA) recep-
tors [17]. Activity-dependent changes in neural circuits require
the NMDA subclass of glutamate receptors [18,19], and alter-
ation of receptor distribution and density is one mechanism by
which synaptic eﬃcacy can be modulated [9]. Although an
NL1 truncation mutation can modulate the amplitude of
glutamatergic mEPSCs [20], little is known about normal func-
tion of NL1 in intact post-natal synapse. We therefore at-
tempted to compromise NL1 function by introducing a point
mutation in position Arg473 analogous to the reported neurol-
igin 3 mutation (Arg451Cys, human sequence numbering),
thus presumably interfering with NL1s ability to couple to
neurexins. To ascertain the role of wild-type and mutant
NL1 in mammalian neurons, we expressed rat wild-type NL1
as well as NL1 with the Arg473Cys mutation (R473C-NL1)
in primary mouse hippocampal cultures, and examined the
consequences on postsynaptic NMDA receptor distribution
and glutamatergic synaptic transmission.2. Materials and methods
2.1. Constructs
The GFPA indicator construct used in this study was as previously
described [21]. FLAG tagged cDNAs encoding rat-NL1 were gener-
ously provided by Davide Comoletti and Palmer Talyor, UCSD [22].
Brieﬂy, constructs consist of NL1 vector encoding the FLAG octapep-
tide at their N-termini and a linker peptide of 10 residues followed by
the NL sequence beginning at Gln-46.
2.2. Culture preparation
Dissociated hippocampal neurons were prepared as previously de-
scribed [23]. DNA constructs were electroporated into the cells as pre-
viously described [21]. The neurons were seeded at high density
(5 · 105 cells/cm2) onto coverslips pretreated with poly-D-lysine
(PDL; 70 kDa, 10 lg/ml, Sigma) o/n, followed by laminin (1 lg/ml,
Sigma) for 3 h, in 24 well plates. Cultures were used for recordings
at between 12 and 15 days, and were maintained in a humidiﬁed atmo-
sphere of 5% carbon dioxide 95% air at 37 C. Cells were fed (Basal
Medium Eagle (BME, Invitrogen)), 0.3% glucose, 5% fetal bovine
serum (FBS, Hyclone), 0.5 mM L-glutamine (Sigma), 10 mM HEPES-
NaOH pH 7.35, 2% B27 (Invitrogen), 15 mM NaPyruvate (Invitro-
gen), 100 lg/ml penicillin–streptomycin (Invitrogen) once a week by
replacing approximately 1/3 of the media.blished by Elsevier B.V. All rights reserved.
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Spontaneous synaptic activity was recorded in the whole-cell conﬁg-
uration of the patch-clamp technique in voltage-clamp mode from
putative pyramidal neurons, after 12–15 days in culture, using an Axo-
patch 200B ampliﬁer (Axon Instruments, Union City, CA), with a
holding potential of 60 mV. The intracellular solution contained
the following (in mM): 100 Cs-gluconate, 1.7 CsCl, 10 ethylene glycol
bis(2-aminoethyl ether)-N,N,N 0N 0-tetraacetic acid (EGTA), 5 MgCl2,
40 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and
adjusted to pH 7.25 with CsOH and supplemented with (in mM): 2
Tris–ATP, 0.5 Na-GTP, and 5 phosphocreatine. The standard extra-
cellular bath solution (EBS) contained the following (in mM): 137
NaCl, 5 KCl, 3 CaCl2, 2 MgCl2, 10 D-glucose, and 5 HEPES, with
an osmolarity of 300 ± 10 mOsm, pH adjusted to 7.3 with NaOH.
For recording AMPA/Kainate miniature excitatory potentials the
EBS contained 0.5 lM TTX (Alomone), 100 lM Picrotoxin (Sigma).
For recording NMDA mEPSCs 50 lM 6-Cyano-7-nitroquinoxaline-
2,3-dione disodium salt (CNQX), and 10 lM glycine were added to
a zero-magnesium version of the EBS in the presence of TTX and pic-
rotoxin.
Experiments were performed at room temperature. Electrodes had a
tip resistances ranging from 5 to 8 MX and the resistance to ground of
the whole-cell seal was 2–8 GX before breakthrough. Only cells with
series resistances less than 40 MX and leaks less than 100 pA were
considered in the analysis. Data was acquired using PClamp9 and a
Digidata 1200 (Axon Instruments) with low-pass ﬁlter (fc) and sam-
pling frequency (fs) settings of fc = 2 KHz and fs = 10 KHz for volt-
age-clamp, and analyzed using PClamp9 and MiniAnalysis
(Synaptosoft Inc). Statistical analyses were performed using SigmaStat
and SPSS (SPSS Inc).
2.4. Immunoﬂuorescence labeling
Culture coverslips were rinsed in warmed phosphate buﬀered saline
(PBS) and ﬁxed in cold 4% paraformaldehyde in PBS for 30 min and
washed, then incubated in the blocking solution (2% donkey serum,
0.2–0.3% Triton-X-100, 450 mM NaCl in 20 mM phosphate buﬀer,
pH 7.4) for 1 h at 4 C and then incubated in the primary antibodies
(diluted in the blocking solution) overnight at 4 C. Either mouse
monoclonal anti-ﬂag (Sigma), anti-NMDAR1 (Sigma) or anti-bassoon
(Sigma) was used as a primary. The coverslips were washed three times
for 15 min in PBS before incubating the coverslips in the appropriateFig. 1. Neuroligin construct expression in hippocampal cultures. Mouse hip
either NL1 or R473C-NL1 (red), detected with mouse anti-ﬂag ab. (A) Red
that it is expressed and transported out to the processes. The co-electroporated
in both the cytoplasm and at the membrane; GFPA indicator (green panel) s
Red panel shows R473C-NL1 protein also localized to membranes (red)
preparations. Magniﬁcation bar in A = 2 lm.donkey secondary antibodies labeled with indocarbocyanine (Cy-3)
1:200 (Jackson Immunoresearch laboratories, West Grove, PA) for
1 h at room temperature.
During some physiology experiments, 1% biocytin was included in
the intracellular solution. The coverslips were rinsed and ﬁxed as above
and the biocytin was then labeled with Streptavidin-Cy3 1:200. The
coverslips were washed and mounted in Vector Shield (Vector Labs,
Burlingame, CA). Images were acquired with a WAT105N (Watec)
camera on an Olympus BX60WI microscope.
2.5. Morphometric analysis
Image analysis was performed using ImageJ (NIH) particle analysis
plug-in.3. Results
3.1. NL1 and R473C-NL1 protein expression in cultured
hippocampal neurons
Mouse hippocampal neurons were electroporated before
plating with the indicator plasmid GFP-actin (GFPA), which
is eﬀective in highlighting cytoskeletal morphology, and either
N-Flag-tagged NL1, N-Flag-tagged R473C-NL1 or alone as a
control. Flag immunostaining of 15 days in vitro (DIV) NL1
expressing neurons showed that the construct was expressed
in neurons and the protein localized to the cell membrane
(Fig. 1A, red). Expression of R473C-NL1 protein was also
found at the membrane and in the processes (Fig. 1B). More-
over, high-resolution imaging indicated that the spines them-
selves possessed both NL-1 and NL1-R473C protein at the
membrane, and ﬂag staining performed on unpermeablized
cells demonstrates that the extracellular domain of the protein
is presented on the surface of the processes (see Supplementary
Material, Fig. 1a–e). It can be seen in the GFPA image of the
R473C-NL1 expressing cells (Fig. 1B, green) that the neurons
have altered morphology of the dendrites and spines. Previouspocampal cultures at 15 DIV, electroporated with GFPA (green) and
panel shows ﬂag antibody staining of the NL1 protein, demonstrating
GFPA construct can be seen in green. (B) R473C-NL1 is also detected
hows altered spine morphology in the R473C-NL1 expressing neurons.
. Staining pattern was observed in neurons from 3 unique culture
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tein, when expressed in non-neuronal cells, or at lower levels in
hippocampal neurons, is retained in the endoplasmic reticulum
[14,15]. However, using our culture and electroporation tech-
niques, in a majority of the neurons the protein was properly
transported to the membrane. In the small percentage of neu-
rons which were unable to transport the bulk of NL1-R473C
protein out of the endoplasmic reticulum, these neurons still
contained detectable levels of protein in the processes (see Sup-
plementary Material, Fig. 1f). These results demonstrate that
both NL1 and R473C-NL1 localize to dendritic structures,
and therefore have the potential to modulate postsynaptic
function directly.
3.2. Modulation of NMDA currents by neuroligin expression
To determine the eﬀect of expression of R473C-NL1 or
overexpressing wild-type NL1 on synaptic transmission, mini-
ature excitatory postsynaptic currents (mEPSCs) arising from
spontaneous vesicle release were recorded from hippocampal
neurons morphologically identiﬁed as pyramidal cells and
expressing GFPA alone, GFPA and NL1, or GFPA and
R473C-NL1. Recorded mEPSCs were analyzed for amplitude,
rise time, decay time and frequency.
To investigate the eﬀects of neuroligin expression solely on
spontaneous NMDA mEPSCs, voltage clamp recordings were
made in the presence of TTX, picrotoxin, a selective AMPA/
Kainate antagonist CNQX, zero Mg2+, and the NMDA co-
agonist glycine. Fig. 2A shows representative tracings from
hippocampal neurons expressing GFPA alone, GFPA and
NL1, or GFPA and R473C-NL1. Strikingly, the R473C muta-
tion in neuroligin has a dramatic eﬀect, causing the appearance
of large amplitude NMDA currents (Fig. 2A, bottom trace).
Higher resolution traces can be seen in Fig. 2B, showing the
characteristic NMDA mEPSCs recorded. In addition to the
population of large amplitude NMDA mEPSCs observed in
neurons expressing R473C-NL1, normal sized currents similar
to those seen in the control and NL1 expressing neurons are
also present. Although this large change in amplitude is signif-
icant (Fig. 2F), neither the frequency of occurrence or rise
times of the mEPSCs is signiﬁcantly altered from control
(Fig. 2C and D), while NMDA mEPSC decay time was longer
(Fig. 2E).
As illustrated in Fig. 2, there appear to be two populations
of NMDA mEPSCs present in neurons expressing the
R473C-NL1 protein. This eﬀect is quantiﬁed by the cumulative
histogram of NMDA amplitudes seen in Fig. 2G, where the
larger amplitude currents present in the R473C-NL1 neurons
results in a shift of the distribution curve. Distribution of
NMDA mEPSC amplitudes in the control and NL1 over-
expressing cells ﬁt a normal distribution (Lilliefors test at
P 6 0.05 and P 6 0.04, respectively), as can be seen in
Fig. 2H and I however this was only approximated in the
R473C-NL1 expressing cells after dividing the amplitudes into
two groups (see Fig. 2J). These data suggest an additional pop-
ulation of large amplitude NMDA mEPSC currents exist in
R473C-NL1 expressing cells.
In contrast to the eﬀect seen with R473C-NL1 expression,
NL1 produces a dramatic eﬀect on NMDA mEPSC frequency
(Fig. 2C) and rise times (Fig. 2D). The increase in frequency is
in concurrence with the reported eﬀect that NL1 overexpres-
sion results in an increase in excitatory synapse number[6,7,24]. The faster rise time suggested a presynaptic or struc-
tural change at the synapse, and combined with the presence
of two populations of R473C-NL1 amplitudes, we accordingly
further pursued the biochemical characterization of the syn-
apse structure.
3.3. Expression of R473C-NL1 protein causes clustering of
NMDA receptors
The observation that postsynaptic NMDA receptor currents
are altered by R473C-NL1 expression suggests that NMDA
receptor distribution in these cells could also be aﬀected.Neurol-
igin family members contain PDZ binding domains that are
hypothesized to interact with the NMDA receptor through an
interactionwithPSD95.Combinedwith the alteredmorphology
of R473C-NL1 expressing neurons, this prompted us to deter-
mine if clustering of the NMDA receptor was diﬀerent in these
neurons. Control neurons expressing GFPA alone demon-
strated a typical staining pattern for the NMDA receptor R1,
with small clusters found on the dendrites (Fig. 3A). Neurons
co-expressing NL1 with GFPA displayed similar sized
NMDAR1 puncta (Fig. 3B). However, it can be seen (Fig. 3C)
that expression ofR473C-NL1 results in the appearance of large
clusters of NMDA receptor protein that is present in the pro-
cesses. While our analysis did not determine if the visualized
NMDAR1 protein was exclusively synaptic, the biological eﬀect
of R473C-NL1 ability to cluster NMDAR1 is demonstrated.
Neurons were analyzed at 5 DIV, as culture and receptor
density rapidly increased pass this point, making discrete visu-
alization diﬃcult. Fig. 3D shows the results of morphometric
analysis of NMDA receptor cluster size, where it can be seen
that both the control GFPA expressing neurons and those also
expressing NL1 had no major diﬀerence in cluster size. Expres-
sion of R473C-NL1 however resulted in a population of very
large clusters that extended several times the average cluster
size in the controls and NL1 expressing cells. Combined with
the NMDAR1 clusters in R473C-NL1 expressing neurons that
are the same size as observed in the controls, this parallels the
presence of two populations of NMDA mEPSCs recorded.
3.4. Modulation of AMPA/Kainate currents by neuroligin
expression
To determine the inﬂuence of wild-type and mutated neurol-
igin expression on synaptic transmission, mEPSCs arising
from spontaneous vesicle release were recorded in whole cell
voltage clamp mode from hippocampal neurons morphologi-
cally identiﬁed as pyramidal cells and expressing GFP-actin
alone, GFP-actin and NL1, or GFP-actin and R473C-NL1.
Recorded mEPSCs were analyzed for amplitude, rise times, de-
cay times and frequency. Fig. 4A shows sample tracings of
AMPA/Kainate mEPSCs, recorded in the presence of TTX,
picrotoxin and 2 mM Mg2+. Fig. 4B shows that expression
of NL1 or R473C-NL1 results in decreased amplitude of the
mEPSCs. In addition, there is a small but signiﬁcant change
in duration of mEPSC rise time with the expression of NL1
(shorter) or R473C-NL1 (longer) (Fig. 4C). While NL1 over-
expression has a minor eﬀect on mEPSC decay, the R473C-
NL1 mutant results in increase in mean decay time
(Fig. 4D). These changes are observed in single mEPSCs (in-
sets in Fig. 4A). Frequency of mEPSCs was unaltered for all
three conditions (Fig. 4E). These data show that the expression
of either NL1 or R473C-NL1 reduces the amplitude of
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expression of R473C-NL1 can potentiate the postsynaptic
depolarization resulting from spontaneous synaptic vesicle re-
lease by lengthening the mEPSC decay time.
These results, when compared to the NMDA population
amplitude data, suggest the NMDA/AMPA ratio increases
dramatically with the expression of R473C-NL1, due primarily
to the contribution of the larger NMDA mEPSC amplitudes.
These data show that the expression of R473C-NL1 strongly
aﬀect the NMDA/AMPA ratio, implicating the expression of
this mutation as a potential modulator of synaptic function.4. Discussion
Neuroligin co-localizes with both the postsynaptic NMDA
receptor and PSD95 [4], and although neuroligin and NMDA
receptors do not bind each other directly [25], each has been
demonstrated to interact with PSD95 [25,26] . Thus neuroligin
is not only present at postsynaptic structures, but is also stra-
tegically positioned potentially to regulate the dynamic process
of synaptic transmission. In this report, we demonstrate that
neuroligin can modulate NMDA receptor distribution and eﬃ-
cacy of NMDA mediated synaptic transmission, a role directly
associating it with synaptic plasticity and cognitive function.
4.1. Morphological changes due to neuroligin expression
Neuroligin expression has been demonstrated to regulate not
only synaptic density [15], but to also the balance betweenFig. 2. Analysis of NMDAmEPSCs reveal two populations in R473C-
NL1 expressing neurons. Voltage-clamp (60 mV) recordings of
mEPSCs from spontaneous NMDA depolarizations in the presence
of 0.5 lM TTX, 100 lM picrotoxin, zero Mg2+, 50 lM CNQX, and
glycine 10 lM. (A) Sample traces from transfected 15 day cultured
mouse hippocampal neurons. Traces are from cells expressing the
control GFPA plasmid, NL1 + GFPA and R473C-NL1 + GFPA. (B)
Higher resolution timescale of traces in A, showing detail of NMDA
mEPSCs under the three conditions. Both small and large NMDA
EPSCs can be observed in neurons expressing R473C-NL1 + GFPA.
(C)Mean frequency of events per minute show an increase in number of
NMDA events in neurons expressing NL-1. (D) Mean values of rise
times of NMDA mEPSCs, showing a faster rise time for currents in
neurons over-expressing NL1, but no change in R473C-NL1 expressing
cells compared to control (GFPA). (E) Mean values of decay times of
NMDA mEPSCs, showing a longer decay time for currents in neurons
expressing R473C-NL1, but no change in NL1 over-expressing cells
compared to control (GFPA). (F) Mean values and (G) cumulative
histogram of amplitude from NMDA mEPSCs, showing an increase in
amplitude of NMDA currents from neurons expressing R473C-NL1,
but no change in NL1 expressing cells. Tracings in Fig. 2 suggest that
there are 2 populations of NMDA mEPSCs amplitudes present in
neurons expressing R473C-NL1. It can be seen in (H) that the
distribution of amplitudes for control (GFPA expressing) NMDA
mEPSCs which follow a normal distribution (Lilliefors test at
P = 0.05). Normal distribution curve is overlaid in green. (I) NL1
over-expressing neurons vary slightly from this curve (Lilliefors test at
P = 0.040, normal distribution curve is overlaid in red). (J) R473C-NL1
fails to be normally distributed (Shapiro–Wilk at P < 0.05, red curve).
However, when the R473C-NL1 amplitude data is divided into two
groups (86.3%/13.7%, which excludes amplitudes 49 pA and over) the
distribution for the smaller events becomes normal (Lilliefors test at
P = 0.04). The distribution of the two groups is illustrated by the two
blue curves. Data obtained from 64 events from each condition,
collected from total of n = 16 cells, taken from 3 independent culture
rounds, analyzed with pClamp v9.0, \ = P < 0.05 on ranked ANOVA
of mean values, S.E.M. error bars.
b
Fig. 3. Expression of R473C-NL1 protein causes clustering of NMDA
receptors. Mouse hippocampal cultures at 5 DIV were electroporated
with GFPA alone, with NL1 + GFPA or with R473C-NL1 + GFPA
and immunostained with anti-NMDAR1 antibody. Images show
staining in dendritic regions.NMDAR1 immdunostaining of (A)GFPA
(B) NL1 + GFPA and (C) R473C-NL1 + GFPA expressing neurons.
Arrows in (C) indicate clusters of NMDAR1 staining. Magniﬁcation
bar = 2 lm. (D) Quantiﬁcation of NMDA cluster size. Data obtained
from tracing and measuring area (ImageJ) of a total of 800 clusters
imaged from n = 8 cells from each condition. While control sized
clusters existed in R473C-NL1 expressing cells, a population of larger
clusters also exist, as indicated by the cumulative histogram.excitatory and inhibitory synapses [27,28], through its interac-
tion with its postsynaptic binding partner PSD95 [29]. These
results illustrate the ability of neuroligin expression to have a
direct structural eﬀect on neuronal architecture. Moreover,
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decrease in amplitude in neurons over-expressing NL1 and R473C-NL1. (C) Rise times from AMPA/Kainate mEPSCs; mean values and cumulative
histogramshowing an increase in fast rise time currents in neurons over-expressingNL1. (D)Decay times forAMPA/KainatemEPSCs;mean values and
cumulative histogram showing a protracted decay time in neurons expressing R473C-NL1. (E) Frequency of events, showing no statistical diﬀerence
between constructs. Data obtained from >2500 randomly selected events collected from cells in each condition (n = 14 total), taken from three
independent culture rounds, analyzed with MiniAnalysis software, \ = P < 0.05 on ranked ANOVA of mean values, displayed with S.E.M. error bars.
6592 H. Khosravani et al. / FEBS Letters 579 (2005) 6587–6594the strong tie between the synaptic scaﬀold proteins such as
PSD95 and the actin cytoskeleton suggest a direct mechanism
by which the morphology of the cells could be altered.
4.2. How does the R473C-NL1 mutation enhance the amplitude
of NMDA currents?
It is possible that the R473C mutation in the NL1 extracellu-
lar domain could result in decreased binding to b-neurexin,
based on the reduced binding to b-neurexin demonstrated for
alternate mutations of the NL1-R473 site [14]. Here, we report
a dramatic eﬀect of NL1-R473C expression on the amplitude of
the NMDA receptor elicited response to spontaneous vesicle
release. We demonstrate that in our cultured hippocampal neu-
rons R473C-NL1 protein is present in the dendrites, and ap-
pears to be associated with the membrane (see Fig. 1). We
then observe a gain of functional NMDA currents in neurons
expressing R473C-NL1, suggesting several explanations. Vari-
ation in the amplitude of NMDA mEPSCs can result from
change in the number of released synaptic vesicles [30]; however
since we saw no equivalent change in AMPA/Kainate currents
(illustrated by the increase in the NMDA/AMPA ratio), this is
unlikely. A more likely explanation would be the increase in the
eﬀective density of the postsynaptic NMDA receptors. Our
observation of NMDAR1 receptor clustering in the postsynap-
tic processes strongly supports this hypothesis. Since the wild-type and mutant NL1 have identical intracellular sequences
they should be both capable of interacting with the NMDA
receptor through proteins such as PSD95 [15,28,16].
However, since wild-type NL1 over-expression did not en-
hance NMDA receptor current amplitudes, the interaction
with the presynaptic neurexin might be a critical aspect of
the regulation of this process, and other studies support this
hypothesis [28]. These results suggest that the possible loss of
b-neurexin binding in R473C-NL1 could result in a loss of
the regulation of synaptic membrane localization of neuroli-
gin, which in turn alters NMDA receptor distribution by virtue
of its interaction through PSD95 (or other PDZ domain con-
taining proteins). This could then result in the formation of
large clusters of NMDA receptors and large receptor currents,
as was observed.
4.3. How does overexpression of wild-type NL-1 aﬀect synaptic
transmission?
When exogenously transfected wild-type NL1 protein was
present in addition to endogenous NL1, the rise times for
excitatory mEPSCs were faster. While this eﬀect could be
caused by a change in the postsynaptic NMDA receptor distri-
bution, increasing the receptor concentration in the region di-
rectly opposite the site of presynaptic release, this was not
observed in our morphometric analysis. An alternative
H. Khosravani et al. / FEBS Letters 579 (2005) 6587–6594 6593explanation for this would be that the excess neuroligin tight-
ens the synaptic cleft, increasing the speed of transmitter diﬀu-
sion. The involvement of presynaptic factors is supported by
the observation that the eﬀect was not observed with the neur-
exin-binding deﬁcient R473C-NL1 mutant. Therefore our data
suggests that endogenous NL-1 could act on the presynapse to
modulate synaptic transmission.
These data demonstrate that when transported to the pro-
cesses, neuroligin 1 carrying the autism-associated mutation
R473C can produce NMDA receptor clustering and a popula-
tion of large amplitude NMDA mEPSCs. When contrasted
with the eﬀect of overexpression of wild-type NL-1, our results
support the hypothesis that presynaptic interaction with neur-
exin is essential for both the regulation of the neurotransmitter
going across the synaptic cleft, as well as the dynamics of the
receptor localization on the postsynaptic side once the trans-
mitter arrives. Recent triple knockout evidence (NL1-3) sug-
gests that the expression of neuroligin is clearly linked to
new synapse formation, but it is not essential [31]. Our data
supports a role for neuroligin as modulator of synaptic trans-
mission, suggesting that neuroligin plays an important role in
the mature CNS. As the process of new synapse formation in
the adult has been demonstrated to occur in response to synap-
tic activity [23], it will be interesting to determine if neuroligin
plays a role in this process. Additionally, since the amplitude
of NMDA and mEPSCs are increased whereas AMPA are
not, this suggests that a situation may occur similar to the acti-
vation of silent synapses [32,33].
NL-1 and NL-3 share >74% sequence identity, and the res-
idue Arg451 (NL3, human), Arg471 (NL3, rat) and Arg473
(NL1, rat) are conserved, and it is tempting to extrapolate
our ﬁndings to what might potentially occur in ASD patients.
Reports propose altered neuroligin 1 and 3 protein traﬃcking
as a contributing factor to autism disorders [14,15]. Also, neu-
roligin expression has been demonstrated to be a key regulator
of the balance between inhibitory and excitatory synapses, and
perturbations of this balance could also result in behavioral
deﬁcits [24,27,29]. Here we demonstrate that, additionally,
the mutant and wild-type NL1 gene products have profoundly
diﬀerent inﬂuences on synaptic transmission, mediated diﬀer-
entially through NMDA and AMPA/Kainate receptor medi-
ated currents. Autism is a brain disorder characterized by
deﬁcits in verbal and non-verbal communication, and in al-
tered social interaction. The dramatic increase in NMDA
receptor currents in neurons expressing the R473C-NL1 muta-
tion, together with the demonstrated role of NMDA receptors
in learning and memory could, in principle, be consistent with
such cognitive dysfunctions.Acknowledgements: We thank A. Sullivan, J. Hung and A. Kertesz for
technical assistance. This work was supported by funds from the Nov-
artis Chair in Schizophrenia Research to M.C., CIHR and AFHMR to
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